Elisheva Pokroy‐Shapira

Author

Tel Aviv University ORCID

Also Known As

E Pokroy-Shapira, E. Pokroy-Shapira, Elisheva Pokroy-Shapira, Elisheva Pokroy‐Shapira

Publications

250

Citations

H-Index

Concepts

All Affiliations

Tel Aviv University Rabin Medical Center Ben-Gurion University of the Negev Tel Aviv Sourasky Medical Center

About

Elisheva Pokroy‐Shapira is an author at Tel Aviv University specializing in medicine, autoimmune disease, and lupus.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	149
2	Immunology	3	3	102
3	Cell Biology	1	1	23
4	Epidemiology	1	1	47
5	Nephrology	1	1	47

Elisheva Pokroy‐Shapira

Publications

239

Citations

H-Index

Page 1

	Year	Citations
Evolution of chronic kidney disease in patients with systemic lupus erythematosus over a long-period follow-up: a single-center inception cohort study Elisheva Pokroy‐Shapira, Ilana Gelernter, Yair Molad Clinical Rheumatology Glomerular DiseaseGlomerulonephritisLong-period Follow-upRenal DiseaseAutoimmune Disease	2014	47
Epstein–Barr virus antibodies mark systemic lupus erythematosus and scleroderma patients negative for anti‐<scp>DNA</scp> Ittai Fattal, Noam Shental, Yair Molad, Immunology Healthy SubjectsScleroderma PatientsImmunologyPathologyImmunotherapy	2013	45
Serum Soluble Triggering Receptor on Myeloid Cells-1 (sTREM-1) is Elevated in Systemic Lupus Erythematosus but does not Distinguish Between Lupus Alone and Concurrent Infection Yair Molad, Elisheva Pokroy‐Shapira, Tania Kaptzan, Inflammation InflammationAutoimmune DiseaseSystemic Lupus ErythematosusConcurrent InfectionLupus	2013	34
CpG-oligodeoxynucleotide-induced TLR9 activation regulates macrophage TREM-1 expression and shedding Yair Molad, Elisheva Pokroy‐Shapira, Vered Carmon Innate Immunity ImmunologyImmune RegulationInnate ImmunityTlr9 ActivationImmune Dysregulation	2013	23
Soluble triggering receptor expressed on myeloid cells‐1 is a biomarker of anti‐<scp>CCP</scp>‐positive, early rheumatoid arthritis Yair Molad, Shachaf Ofer‐Shiber, Elisheva Pokroy‐Shapira, European Journal of Clinical Investigation	2015	19
Lower socioeconomic status worsens outcome of patients with systemic lupus erythematosus independently of access to healthcare Iftach Sagy, Yarden Cohen, Yehudit Nahum, Lupus	2022	18
Elevated plasma level of soluble triggering receptor expressed on myeloid cells-1 is associated with inflammation activity and is a potential biomarker of thrombosis in primary antiphospholipid syndrome Yonatan Edel, Vitaly Kliminski, Elisheva Pokroy‐Shapira, Arthritis Research & Therapy	2019	15
A Cross-sectional Survey on the Preference of Patients with Rheumatoid Arthritis for Route of Administration of Disease-Modifying Anti-Rheumatic Drugs: Oral Target-Specific Versus Parenteral Biologic. Yonatan Edel, Iftach Sagy, Elisheva Pokroy‐Shapira, PubMed	2020	15
Systemic lupus erythematosus exacerbation following cessation of belimumab treatment Victoria Furer, Devy Zisman, Elisheva Pokroy‐Shapira, Scandinavian Journal of Rheumatology	2015	13
<i>Capnocytophaga</i>bacteraemia following rituximab treatment Elisheva Pokroy‐Shapira, Shachaf Shiber, Yair Molad BMJ Case Reports	2012	10

Page 1